The “Stem Cell/Cord Blood Banking Global Market Report 2021: COVID-19 Growth and Change to 2030” report has been added to ResearchAndMarkets.com’s offering.
The global stem cell/cord blood banking market is expected to grow from $8.16 billion in 2020 to $8.61 billion in 2021 at a compound annual growth rate (CAGR) of 5.5%. The market is expected to reach $12.51 billion in 2025 at a CAGR of 9.8%.
Major players in the stem cell/cord blood banking market are AMAG Pharmaceuticals, Cordlife, Cryo-Cell International, Esperite, and Americord Registry LLC.
The stem cell/cord blood banking global market consists of sales of stem cell/cord blood banking services and related goods. Cord stem cells are referred to as regenerative medicines which help in regeneration of tissues or cells in the body. Stem cells therapy is designed to aid the physician in performing medical treatment of different types of cancers, neurodegenerative diseases, graft-versus-host disease and heart diseases.
The stem cell/cord blood banking market covered in this report is segmented by cell type into adult stem cells, umbilical cord blood stem cells, embryonic stem cells. It is also segmented by service into collection, processing, analysis, storage; by bank type into public, private and by application into leukemia, anemia, thalassemia, autism, cerebral palsy, diabetes, others.
Lack of awareness especially among pregnant women is a major restraint for the stem cell/cord blood banking market. This is mainly because a majority of pregnant women are unaware of the functioning of the public cord blood banks. Hence, this option is not fully explored despite the advantages of stem cell transplantation in treating cancer.
For example, according to the survey by International Journal of Reproduction, Contraception, Obstetrics and Gynecology (IJRCOG), only 45% of pregnant women were informed about the uses of umbilical cord blood during pregnancy, just 5% were aware about the cost of the procedure and less than 1% were aware about the availability of cord blood banking.
Pairing of cord blood and tissue storage with genetic testing services is an emerging trend in the stem cell/cord blood banking market. Such pairing is possible and efficient because of its complimentary services to the existing clients, thereby helping in expanding their product portfolio. For example, genetic testing company Natera launched the Evercord cord blood and tissue storage service that enables expectant parents to collect, store and potentially retrieve their newborn’s cord blood and tissue for therapeutic use in transplantation and regenerative medicine applications.
Increasing number of cancer patients is a major driver for the stem cell /cord blood banking market. Cancer diseases such as leukemia and multiple myeloma can be treated by stem cell transplant. In stem cell transplant, treatment can be either done by autologous transplant in which the stem cells come from the same person who gets the transplant or by allogeneic transplant in which means the stem cells come from a matched related or unrelated donor.
The US Food and Drug Administration (FDA) outlines guidance related to stem cells/cord blood banking in accordance with section 212 of the Small Business Regulatory Enforcement Fairness Act (Public Law 104-121). As per this act, stem cells sourced from cord blood for unrelated allogeneic use are regulated by the FDA, and, in order to distribute these products, distributors need to get a license from the FDA.
These licenses are provided by the FDA after reviewing the manufacturing and the storage conditions. In this regard, the American Association of Blood Banks (AABB) and other regulatory agencies also work with the FDA. Hence, the regulatory scenario related to the stem cells/cord blood banking market is expected to keep a check on companies involved in this market.
Key Topics Covered:
1. Executive Summary
2. Stem Cell/Cord Blood Banking Market Characteristics
3. Stem Cell/Cord Blood Banking Market Trends and Strategies
4. Impact Of COVID-19 On Stem Cell/Cord Blood Banking
5. Stem Cell/Cord Blood Banking Market Size and Growth
5.1. Global Stem Cell/Cord Blood Banking Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Stem Cell/Cord Blood Banking Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. Stem Cell/Cord Blood Banking Market Segmentation
6.1. Global Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
- Adult Stem Cells
- Umbilical Cord Blood Stem Cells
- Embryonic Stem Cells
6.2. Global Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
6.3. Global Stem Cell/Cord Blood Banking Market, Segmentation by Bank Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
6.4. Global Stem Cell/Cord Blood Banking Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
- Cerebral palsy
7. Stem Cell/Cord Blood Banking Market Regional and Country Analysis
7.1. Global Stem Cell/Cord Blood Banking Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Stem Cell/Cord Blood Banking Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
- AMAG Pharmaceuticals
- Cryo-Cell International
- Americord Registry LLC
- China Cord Blood Corporation
- Cordlife Group Limited
- ESPERITE N.V.
- Cryo Stemcell
- Smart Cells International
- Stemade Biotech
- LifeCell International
- Cryoviva India
- Cytori Therapeutics
- Thermo Fisher Scientific
- Cord Blood America Inc.
- Stem Cyte
- Brainstorm Cell Therapeutics
For more information about this report visit https://www.researchandmarkets.com/r/587yea
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900